Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-01-12T02:43:57.194Z Has data issue: false hasContentIssue false
  • English
  • Français

Antidepressants: uses and attitudes among consultant psychiatrists – A questionnaire study

Published online by Cambridge University Press:  13 June 2014

Brian O'Shea
Brian O'Shea*
Affiliation:
Newcastle Hospital, Greystones, Co. Wicklow; Clinical Lecturer in Psychiatry, University College Dublin
Get access Rights & Permissions [Opens in a new window]

Abstract

An audit of Consultant Psychiatrists' views on and uses of antidepressant drugs is reported. At present senior prescribers largely opt for the older tricyclic antidepressants despite a knowledge of their shortcomings. MAOIs are less popular and newer drugs are viewed cautiously and apprehensively. Lofepramine is largely viewed as an alternative to dothiepin and amitriptyline. Non-drug strategies in the management of depression consist largely of support, environmental manipulation and electroconvulsive therapy. The relatively novel treatment, cognitive therapy, has a strong minority following.

Keywords

DepressionAntidepressantsQuestionnaireConsultant PsychiatristsPreferenceAttitudes
Type
Practice Review
Information
Irish Journal of Psychological Medicine , Volume 8 , Issue 2 , September 1991 , pp. 167 - 170
Copyright
Copyright © Cambridge University Press 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Royal College of Psychiatrists. Statement on approval of training schemes for general professional training for the MRCPsych. Psychiat Bull 1990; 14: 110–118.CrossRefGoogle Scholar
2. Government of Ireland, Department of Health. Health Statistics 1989. Dublin: Stationery Office, 1990.Google Scholar
3.Pare, CMB. The present status of monoamine oxidase inhibitors. Br J Psychiat 1985; 146: 576–584.CrossRefGoogle ScholarPubMed
4.Kennedy, SH, Joffe, RT. Pharmacological management of refractory depression. Can J Psychiat 1989; 34: 451–455.CrossRefGoogle ScholarPubMed
5.O'Shea, B. Alprazolam: just another benzodiazepine? Ir J Psychol Med 1989; 6: 89–94.CrossRefGoogle Scholar
6.O'Shea, B. Antidepressant cardiotoxicity. Ir Med J 1985; 78: 22–24.Google ScholarPubMed
7.Hawton, K. Long-term outcome studies of psychological treatments. In: Freeman, C, Tyrer, P, editors. Research methods in psychiatry. London: Gaskell, 1989.Google Scholar